Financials
Financial year 2025
DR. VINCK - DR. DELMOTTE from Zemst, company number BE0892315668, closed financial year 2025 with a result of € 482,094 after tax. For that financial year DR. VINCK - DR. DELMOTTE recorded a gross margin of € 685,393 and equity of € 2.3 million. Compared with financial year 2024, the result moved from € 468,474 to € 482,094. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 5, 2026.
€ 2.3 million
▲ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 482,094
▲ 3% vs 2024
Profit after tax over the fiscal year.
€ 518,999
▼ 63% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 180,000 paid out
37 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 806
▼ 73% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 85,767
▲ 26% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 484,896 | € 642,287 | € 655,981 | € 685,393 | ▲ 4% |
| Profit after taxes | € 353,649 | € 444,917 | € 468,474 | € 482,094 | ▲ 3% |
| Equity | € 1,122,844 | € 1,561,706 | € 1,962,179 | € 2,264,273 | ▲ 15% |
| Total debts | € 117,703 | € 108,667 | € 74,662 | € 133,860 | ▲ 79% |
| Cash | € 755,469 | € 1,182,279 | € 1,409,759 | € 518,999 | ▼ 63% |
| Retained profit | € 1,122,844 | € 1,559,706 | € 1,960,179 | € 2,262,273 | ▲ 15% |
| Dividend | € 317,235 | € 0 | € 68,000 | € 180,000 | ▲ 165% |
| Bank debt | € 17,261 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 1,240,548 | € 1,670,373 | € 2,036,841 | € 2,398,134 | ▲ 18% |
Key figures of DR. VINCK - DR. DELMOTTE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
Ask about DR. VINCK - DR. DELMOTTE the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to DR. VINCK - DR. DELMOTTE?
What happened at DR. VINCK - DR. DELMOTTE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 482,094 (▲ 3% vs 2024). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 353,649 profit in 2022 to € 482,094 profit in 2025.
Paid € 741,735 in corporate taxes since 2022.
Best year ever: 2025, with € 482,094 profit.
Paid out € 565,235 in dividends to the owners in total.
Management
Behind DR. VINCK - DR. DELMOTTE are Wouter Vinck and Alexandra Delmotte.
Directors
According to the 2025 annual accounts
Wouter Vinck
Director
Alexandra Delmotte
Director
Establishments
Establishment units
Physical locations of this company
Klaproosstraat 22
1981 Zemst
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0892.315.668
- VAT number
- BE 0892.315.668
- Registered office
- Klaproosstraat 22, 1981 Zemst
- Names & denominations
- DR. VINCK - DR. DELMOTTE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 September 2007
- Peppol
- Active · Active since 10 Dec 2025